Skip to main content

Table 2 Preprocedural and postprocedural echocardiography data, Intraprocedural information

From: Repeat transcatheter aortic valve implantation using a latest generation balloon-expandable device for treatment of failing transcatheter heart valves

  Patient no. 1 Patient no. 2 Patient no. 3
TTE/TEE before 2nd procedure    
 LVEF (%) 60 50 30
 Gradient max/mean (mm Hg) 18/9 24/12 15/12
 EOA (cm2) 1.7 2.2 2.3
 Valve insufficiency severe moderate-severe severe
 ViV procedure Edwards Sapien XT JenaValve CoreValve
 Edwards Sapien 3 size (mm) 26 29 29
 Procedure time (mm) 95 100 180
 Fluoroscopy time (min) 10 11 20
 Contrast agent (mL) 121 125 174
TTE discharge    
 LVEF (%) 60 50 30
 EOA (cm2) 1.5 2.5 2.5
 Gradient max/mean (mm Hg) 36/16 17/9 14/6
 Paravalvular leakage none trace trace
ICU stay (d) 2 1 1
Hospital stay (d) 10 8 20
VARC-2 events at 30 days Major bleeding None TIA
  1. TTE transthoracic echocardiography; TEE transesophageal echocardiography; LVEF left ventricular ejection fraction; ViV valve-in-valve; mm millimeter; min minutes; mL milliliter; EOA effective orifice area; ICU intensive care unit; VARC-2 Valve academic research consortium; TIA transitory ischemic attack; SD standard deviation